FHL2 and neoplasm: The results showed that tumor sizes in ApcΔ14/+FHL2−/− mice were not significantly different from those in ApcΔ14/+FHL2+/+ mice (p>0.2, Wilcoxon Rank Sum test), suggesting that loss of FHL2 activity does not affect tumor growth.